Screening first-degree relatives of glaucoma patients reveals barriers to participation.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
05 2022
Historique:
received: 09 06 2020
revised: 26 11 2020
accepted: 11 12 2020
pubmed: 10 1 2021
medline: 26 4 2022
entrez: 9 1 2021
Statut: ppublish

Résumé

To report the results of a glaucoma screening campaign targeting first-degree relatives of glaucoma patients in South India. 1598 glaucoma patients were contacted via letter or letter and phone call and asked to bring their siblings and children to a glaucoma screening. Participants underwent standardised eye examinations and completed questionnaires that assessed barriers to participation and awareness of glaucoma risk. Two-proportion z-tests were used to compare categorical data. Costs associated with the screening were recorded. 206 probands (12.9%) attended the screening along with 50 siblings and children. Probands were nearly twice as likely to attend if they had been contacted via both letter and phone call rather than letter only. Over half of probands reported that their relatives could not participate because they did not live in the region, and one-fifth reported that their relatives had other commitments. Fifty-eight per cent of the siblings and children who attended did not know that they were at increased risk for glaucoma due to their family history, and 32.0% did not know that the relative who had invited them to the screening had glaucoma. Thirteen siblings and children (26.0% of those who attended) were found to have findings concerning for glaucoma. The average cost per first-degree relative who was screened was INR2422 (£26). Participation in this glaucoma screening campaign was poor. The major barrier to participation was distance from the screening site and associated indirect costs. Better strategies for bringing first-degree relatives in for examinations are needed.

Identifiants

pubmed: 33419787
pii: bjophthalmol-2020-317176
doi: 10.1136/bjophthalmol-2020-317176
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

655-659

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sujani Shroff (S)

Glaucoma Services, Aravind Eye Hospital, Madurai, India.

Sophie Z Gu (SZ)

Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Ashok Vardhan S (A)

Glaucoma Services, SV Aravind Eye Hospital, Tirupati, Andhra Pradesh, India ashokvar@aravind.org.

Iswarya Mani (I)

Department of Biostatistics, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Kanza Aziz (K)

Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Namperumalsamy P (N)

Aravind Eye Hospital, Madurai, India.

Dipankar Datta (D)

Cataract and Glaucoma Services, Aravind Eye Hospital, Theni, Tamil Nadu, India.

David S Friedman (DS)

Glaucoma Center of Excellence, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH